ENS 46791: Difference between revisions
Jump to navigation
Jump to search
StriderTol (talk | contribs) (Created page by program invented by Mark Hawes) |
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
||
| Line 16: | Line 16: | ||
| event date = 04/27/2011 10:45 EDT | | event date = 04/27/2011 10:45 EDT | ||
| last update date = 04/27/2011 | | last update date = 04/27/2011 | ||
| title = Patient Received Less | | title = Patient Received Less than Prescribed Dose Due to an Occlusion in the Delivery Catheter | ||
| event text = A patient received 14.8 Gray rather than the 63 Gray prescribed treatment to the upper portion of the liver using SIRSpheres manufactured by Sirtex. Only 0.7 GBq of the 3 GBq Y-90 microspheres were delivered to the treatment site due to an occlusion in the micro catheter. The treating physician terminated the dose administration after encountering difficulty in "pushing" the syringe contents through the micro catheter. While removing the catheter a small release of microspheres occurred due to the trapped pressure. The spill was contained and immediately cleaned up. | | event text = A patient received 14.8 Gray rather than the 63 Gray prescribed treatment to the upper portion of the liver using SIRSpheres manufactured by Sirtex. Only 0.7 GBq of the 3 GBq Y-90 microspheres were delivered to the treatment site due to an occlusion in the micro catheter. The treating physician terminated the dose administration after encountering difficulty in "pushing" the syringe contents through the micro catheter. While removing the catheter a small release of microspheres occurred due to the trapped pressure. The spill was contained and immediately cleaned up. | ||
The Hospital contacted the manufacturer and will return the dose unit for analysis. Both the patient and the referring physician have been informed. There was no adverse impact to the patient who has been rescheduled for a compensatory dose next week. | The Hospital contacted the manufacturer and will return the dose unit for analysis. Both the patient and the referring physician have been informed. There was no adverse impact to the patient who has been rescheduled for a compensatory dose next week. | ||
Latest revision as of 22:07, 1 March 2018
| Where | |
|---|---|
| Beaumont Hospitals Royal Oak, Michigan (NRC Region 3) | |
| License number: | 21-01333-01 |
| Organization: | Beaumont Hospitals |
| Reporting | |
| 10 CFR 35.3045(a)(1) | |
| Time - Person (Reporting Time:+1.33 h0.0554 days <br />0.00792 weeks <br />0.00182 months <br />) | |
| Opened: | Sheryl Schultz 16:05 Apr 27, 2011 |
| NRC Officer: | Steve Sandin |
| Last Updated: | Apr 27, 2011 |
| 46791 - NRC Website | |